6kxx
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Human PPAR alpha ligand binding domain in complex with a synthetic agonist (compound A)== | ==Human PPAR alpha ligand binding domain in complex with a synthetic agonist (compound A)== | ||
- | <StructureSection load='6kxx' size='340' side='right'caption='[[6kxx]]' scene=''> | + | <StructureSection load='6kxx' size='340' side='right'caption='[[6kxx]], [[Resolution|resolution]] 1.95Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6KXX OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[6kxx]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6KXX OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6KXX FirstGlance]. <br> |
- | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.95Å</td></tr> |
+ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=T02:1-(4-chlorophenyl)-6-methyl-3-propan-2-yl-pyrazolo[3,4-b]pyridine-4-carboxylic+acid'>T02</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6kxx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6kxx OCA], [https://pdbe.org/6kxx PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6kxx RCSB], [https://www.ebi.ac.uk/pdbsum/6kxx PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6kxx ProSAT]</span></td></tr> | ||
</table> | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/PPARA_HUMAN PPARA_HUMAN] Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety (By similarity). Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the ACOX1 and P450 genes. Transactivation activity requires heterodimerization with RXRA and is antagonized by NR2C2.<ref>PMID:7684926</ref> <ref>PMID:7629123</ref> <ref>PMID:9556573</ref> <ref>PMID:10195690</ref> | ||
+ | |||
+ | ==See Also== | ||
+ | *[[Peroxisome proliferator-activated receptor 3D structures|Peroxisome proliferator-activated receptor 3D structures]] | ||
+ | == References == | ||
+ | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
+ | [[Category: Homo sapiens]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Doi M]] | [[Category: Doi M]] |
Current revision
Human PPAR alpha ligand binding domain in complex with a synthetic agonist (compound A)
|
Categories: Homo sapiens | Large Structures | Doi M | Doi T | Fukuda S | Ishimoto K | Kawahara K | Miyachi H | Ohkubo T | Oki H | Tabata R | Tachibana K | Yoshida T | Yuzuriha T